Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial

Autor: Ignatius Ou, SaiHong, Planchard, David, Park, Keunchil, Schuler, Martin, Yang, James, Chand, Vikram, Rohr, Klaus, Bagnes, Claudia, Martin, Claudio Marcelo, Recondo, Gonzalo, Zarba, Juan Jose, Blajman, Cesar, Richardet, Martín, McLachlan, Sue-Anne, Parente, Phillip, Underhill, Craig, Crombie, Catherine, Mainwaring, Paul, Greil, Richard, Humblet, Yves, Bustin, Frédérique, Carestia, Luciano, Galdermans, Danny, Lambrechts, Marc, Delval, Laetitia, Vercauter, Piet, Zhou, Caicun, Wang, Jin, Huang, Cheng, Lin, Xiaoyan, Wu, Yilong, Liu, Xiaoqing, Cheng, Ying, Qin, Shukui, Feng, Jifeng, Huang, Jianjin, Zhang, Yiping, Lu, Shun, Zereu, Manuela, Garicochea, Bernardo, Zadra, Cyntia Albuquerque, Riska, Henrik, Alanko, Tuomo, Cadranel, Jacques, Chouaid, Christos, Zalcman, Gérard, Sibilot, Denis Moro, Perol, Maurice, Bennouna, Jaafar, Fournel, Pierre, Gervais, Radj, Rotarski, Maciej, Coudert, Bruno, Thomas, Michael, Wehler, Thomas, Faehling, Martin, Keilholz, Ulrich, Laack, Eckart, von Pawel, Joachim, Huber, Rudolf, Dickgreber, Nicolas, Wiewrodt, Rainer, Mark, Zsuzsanna, Tehenes, Sandor, Strausz, Janos, Sarosi, Veronika, Prabhash, Kumar, Jain, Minish, Venkatesan, Srinivasan, Sharma, Lalit, Dadhich, Hemant, Nagarkar, Rajnish Vasant, Onn, Amir, Gottfried, Maya, Stemmer, Solomon, Migliorino, Maria Rita, Grossi, Francesco, Bidoli, Paolo, Bearz, Alessandra, Gridelli, Cesare, Milandri, Carlo, Platania, Marco, Ceresoli, Giovanni Luca, Cruciani, Giorgio, Delgado, Francisco Gutierrez, Gonzalez Perez, José Luis, Luna, Gabriela Alvarado, Baca, Othon Padilla, Aerts, J.G.J.V., Stigt, J.A., Dingemans, A.M.C., Herder, G.J.M., Gans, S.J.M., Salas Sánchez, Jorge Fernando, Alvarez Barreda, Renzo Luzgardo, Pantigoso, Wilbert Rodriguez, Palomino, Osbert Luis Mejia, Jaskiewicz, Piotr, Kazarnowicz, Andrzej, Serwatowski, Piotr, Szczesna, Aleksandra, Jassem, Jacek, Lubennikov, Vladimir, Karaseva, Nina, Orlov, Sergey, Ragulin, Yuri, Garrido, Pilar, González Larriba, José Luis, Camps, Carlos, Campelo, Rosario García, Lianes, Pilar, Cobo, Manuel, Felip, Enriqueta, Kim, Dong-Wan, Kim, Sang-We, Kim, Joo-Hang, Han, Ji-Youn, Kim, Young-Chul, Yang, Chih-Hsin, Hsia, Te-Chun, Chen, Yuh-Min, Tsai, Ying-Huang, Chang, Gee-Chen, Tsao, Thomas Chang-Yao, Su, Wu-Chou, Huang, Ming-Shyan, Ho, Ching-Liang, Hsieh, Ruey-Kuen, Vinnyk, Yuriy, Popovych, Oleksandr, Ponomarova, Olga, Bondarenko, Igor, Polishchuk, Iryna, Shah, Riyaz, Mitra, Sanka, Popat, Sanjaykumar, Spicer, James, Toy, Elizabeth, Talbot, Toby, Brown, Emma, Upadhyay, Sunil, Summers, Yvonne, Gurtler, Jayne, Meza, Luis, Thropay, John, Schuler, M. ^*, Yang, J.C.-H., Park, K., Kim, J.-H., Bennouna, J., Chen, Y.-M., Chouaid, C., De Marinis, F., Feng, J.-F., Grossi, F., Kim, D.-W., Liu, X., Lu, S., Strausz, J., Vinnyk, Y., Wiewrodt, R., Zhou, C., Wang, B., Chand, V.K., Planchard, D.

Publikováno v: In Annals of Oncology March 2016 27(3):417-423

Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer.

Autor: Park, Keunchil¹ (AUTHOR) kpark@skku.edu, Bennouna, Jaafar² (AUTHOR) jaafar.bennouna@univ-nantes.fr, Boyer, Michael³ (AUTHOR) michael.boyer@lh.org.au, Hida, Toyoaki⁴ (AUTHOR) 107974@aichi-cc.jp, Hirsh, Vera⁵ (AUTHOR) vera.hirsh@muhc.mcgill.ca, Kato, Terufumi⁶ (AUTHOR) terufumikato@gmail.com, Lu, Shun⁷ (AUTHOR) shun_lu@hotmail.com, Mok, Tony⁸ (AUTHOR) tony@clo.cuhk.edu.hk, Nakagawa, Kazuhiko⁹ (AUTHOR) nakagawa@med.kindai.ac.jp, O'Byrne, Kenneth¹⁰ (AUTHOR) k.obyrne@qut.edu.au, Paz-Ares, Luis¹¹ (AUTHOR) lpazaresr@seom.org, Schuler, Martin¹² (AUTHOR) Martin.Schuler@uk-essen.de, Sibilot, Denis Moro¹³ (AUTHOR) dmoro-sibilot@chu-grenoble.fr, Tan, Eng-Huat¹⁴ (AUTHOR) dmoteh@nccs.com.sg, Tanaka, Hiroshi¹⁵ (AUTHOR) htanaka@niigata-cc.jp, Wu, Yi-Long¹⁶ (AUTHOR) syylwu@live.cn, Yang, James C.-H.¹⁷ (AUTHOR) chihyang@ntu.edu.tw, Zhang, Li¹⁸ (AUTHOR) Zhangli6@mail.sysu.edu.cn, Zhou, Caicun¹⁹ (AUTHOR) caicunzhoudr@163.com, Märten, Angela²⁰ (AUTHOR) angela.maerten@boehringer-ingelheim.com

Publikováno v: Lung Cancer (01695002). Jun2019, Vol. 132, p126-131. 6p.